ES476917A1 - Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico. - Google Patents

Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.

Info

Publication number
ES476917A1
ES476917A1 ES476917A ES476917A ES476917A1 ES 476917 A1 ES476917 A1 ES 476917A1 ES 476917 A ES476917 A ES 476917A ES 476917 A ES476917 A ES 476917A ES 476917 A1 ES476917 A1 ES 476917A1
Authority
ES
Spain
Prior art keywords
carboxylic acid
acid derivatives
preparation
pyridone
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476917A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH51278A external-priority patent/CH639073A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES476917A1 publication Critical patent/ES476917A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES476917A 1978-01-18 1979-01-17 Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico. Expired ES476917A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH51278A CH639073A5 (en) 1978-01-18 1978-01-18 4-Pyridone-3-carboxylic acid derivatives and their preparation
CH1173478 1978-11-15

Publications (1)

Publication Number Publication Date
ES476917A1 true ES476917A1 (es) 1979-11-16

Family

ID=25684790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476917A Expired ES476917A1 (es) 1978-01-18 1979-01-17 Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.

Country Status (25)

Country Link
US (2) US4521535A (OSRAM)
EP (1) EP0003144B1 (OSRAM)
JP (1) JPS54100382A (OSRAM)
KR (1) KR820002111B1 (OSRAM)
AR (1) AR223663A1 (OSRAM)
AT (1) AT369731B (OSRAM)
AU (1) AU521148B2 (OSRAM)
CA (1) CA1110234A (OSRAM)
DE (1) DE2901868A1 (OSRAM)
DK (1) DK20279A (OSRAM)
ES (1) ES476917A1 (OSRAM)
FI (1) FI790103A7 (OSRAM)
FR (1) FR2415103A1 (OSRAM)
GB (1) GB2013190B (OSRAM)
GR (1) GR73088B (OSRAM)
HU (1) HU179487B (OSRAM)
IE (1) IE47784B1 (OSRAM)
IL (1) IL56421A (OSRAM)
LU (1) LU80794A1 (OSRAM)
MC (1) MC1239A1 (OSRAM)
NL (1) NL7900264A (OSRAM)
NO (1) NO152089C (OSRAM)
NZ (1) NZ189379A (OSRAM)
PT (1) PT69093A (OSRAM)
SE (1) SE7900318L (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125762A (en) * 1979-07-13 1982-06-15 Alexander E. Wick Dihydronicotinic acid derivatives and process for the preparation thereof
US4964896A (en) * 1980-05-12 1990-10-23 Monsanto Company Certain-2,6-diphenyl-1,4-dihydro-4-oxo-nicotinates which are useful for inducing male sterility in cereal grain plants
US4936904A (en) * 1980-05-12 1990-06-26 Carlson Glenn R Aryl-4-oxonicotinates useful for inducing male sterility in cereal grain plants
US4714492A (en) * 1980-05-12 1987-12-22 Rohm And Haas Company Certain 2-phenyl-4-oxo-nicotinates and their use for inducing male sterility in a cereal grain plant
ZA813029B (en) * 1980-05-12 1982-05-26 Rohm & Haas Novel substituted oxonicotinates,their use as plant growth regulators and plant growth regulating compositions containing them
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben
JPS5980665A (ja) * 1982-10-29 1984-05-10 Toyama Chem Co Ltd 4−オキソ−1,4−ジヒドロニコチン酸誘導体
GB8502424D0 (en) * 1985-01-31 1985-03-06 Pharis R P Promotion of flowering fruit trees
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
EP2149547A1 (en) * 2008-07-30 2010-02-03 LEK Pharmaceuticals D.D. Process for the synthesis of ezetimibe and intermediates useful therefor
US9988373B2 (en) 2013-12-26 2018-06-05 Shionogi & Co., Ltd. Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
IN142614B (OSRAM) * 1974-08-28 1977-08-06 Lilly Co Eli
CA1125762A (en) * 1979-07-13 1982-06-15 Alexander E. Wick Dihydronicotinic acid derivatives and process for the preparation thereof
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben

Also Published As

Publication number Publication date
JPS54100382A (en) 1979-08-08
GB2013190A (en) 1979-08-08
DK20279A (da) 1979-07-19
FR2415103B1 (OSRAM) 1982-11-05
NZ189379A (en) 1984-07-06
IE47784B1 (en) 1984-06-13
US4521535A (en) 1985-06-04
AU4329679A (en) 1979-07-26
IE790113L (en) 1979-07-18
FI790103A7 (fi) 1979-07-19
GR73088B (OSRAM) 1984-02-01
KR820002111B1 (ko) 1982-11-10
AT369731B (de) 1983-01-25
EP0003144B1 (de) 1981-08-05
CA1110234A (en) 1981-10-06
IL56421A (en) 1982-08-31
DE2901868A1 (de) 1979-07-19
EP0003144A2 (de) 1979-07-25
PT69093A (en) 1979-02-01
GB2013190B (en) 1982-07-14
NO152089C (no) 1985-08-14
US4549022A (en) 1985-10-22
MC1239A1 (fr) 1979-10-26
SE7900318L (sv) 1979-07-19
NO790165L (no) 1979-07-19
ATA35079A (de) 1982-06-15
HU179487B (en) 1982-10-28
EP0003144A3 (en) 1979-08-08
AU521148B2 (en) 1982-03-18
IL56421A0 (en) 1979-03-12
LU80794A1 (de) 1980-02-14
NL7900264A (nl) 1979-07-20
FR2415103A1 (fr) 1979-08-17
AR223663A1 (es) 1981-09-15
NO152089B (no) 1985-04-22

Similar Documents

Publication Publication Date Title
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DE2861045D1 (en) Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections
MX9205208A (es) Compuestos derivados del acido 5-amino-4-hidroxihexanoico, procedimiento para su preparacion y compociciones farmaceuticas que los contienen
ES2012927A6 (es) Procedimiento para preparar derivados de adenosina.
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
MX9304793A (es) Glicanas de actividad inmunoestimulante.
US4016179A (en) Certain esters of 2-substituted-4-hydroxy-cyclopent-2-enones
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
DK542781A (da) Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf
ES8606362A1 (es) "un procedimiento para preparar un derivado de cefem".
MX9305510A (es) Compuestos para el tratamiento o profilaxis de desordenes gastrointestinales, cardiovasculares y del sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2074530T3 (es) Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos.
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
MX3897E (es) Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido)
ES447732A1 (es) Procedimiento para la preparacion de autraquinon-bis-amidi- nas.
ES8405013A1 (es) Procedimiento para preparar derivados de tieno-tiazol
IL57939A (en) Pharmaceutical compositions containing n-substituted aziridine-2-carboxylic acid derivatives,some such novel compounds and processes for the preparation of said n-substituted aziridine-2-carboxylic acid derivatives
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
MX9302429A (es) Nuevas tetralonas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
AR213932A1 (es) Nuevos compuestos de n-alquilcarbamato de(o-alquil-s-alquil-fosforiloxi o tiofosfosiloxi)-benzaldoxima,-acetofenonoxima o propiofenonoxima,procedimiento para su preparacion y composiciones insecticidas,acaricidas y nematocidas que los contienen
ES543797A0 (es) Procedimiento de preparacion de nuevos derivados benzohi- drilpiperacinos y sus sales de adicion acidas
ES8206544A1 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
GB1328169A (en) Benzamide compounds and methods for their production